Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts DetailsTitle Grant Type Focus Area Country Application Due Date Investigating the Benefit of Early Treatment with Ritlecitinib in Alopecia Areata: A Real-World Evidence ApproachRelease Date:Research Inflammation & Immunology USA Guideline Concordant Care and Emerging Data for Patients with MIBC through la/mUCEducation Oncology USA Advancing Genomic Competence and Patient Centered Care in Metastatic Breast CancerRelease Date:Education Oncology Canada, China, France, Germany, India, Italy, Japan, Spain, United Kingdom AI-Enabled Models for Timely COVID-19 Treatment with Nirmatrelvir/Ritonavir: Eligibility & Drug–Drug Interaction ManagementRelease Date:Research Internal Medicine Australia, Canada, Germany, Greece, Japan, Korea, Taiwan Clinical Data Updates on Long Term Outcomes and Practical Therapy Management Strategies in First-line ALK-positRelease Date:Education Oncology United States Minor Outlying I OPTIMA-HEMA Project: Optimizing the Management and Application of Novel Immunotherapies in Hematologic MalignanciesRelease Date:Quality Improvement Oncology China Advancing Adult Immunization Strategies:A Focus on the Impact of Respiratory Syncytial Virus(RSV) and Cardiorespiratory OutcomeRelease Date:Education Vaccines USA Implementing Shared Decision Making in Hemophilia Patient CareRelease Date:Quality Improvement Rare Disease USA Transthyretin Cardiac Amyloidosis FellowshipRelease Date:Fellowship Internal Medicine Germany Title Grant Type Focus Area Country Application Due Date Accelerating biomarker testing for optimized metastatic colorectal cancer treatment planning across CanadaRelease Date:Partner: Colorectal Cancer Canada (CCC)Quality Improvement, Research Oncology Canada Integrin beta-6 (IB6) Sigvotatug Vedotin (SV) Translational and Pre-Clinical ResearchRelease Date:Research Oncology All 2025 Inflammatory Bowel Disease (IBD) Fellowship – United StatesRelease Date:Fellowship Inflammation & Immunology USA PARP-inhibitor Combination Treatments: Efficacy and Safety in a New Era of metastatic Castration Resistant Prostate CancerRelease Date:Education Oncology China Transthyretin Cardiac Amyloidosis Fellowship - United StatesRelease Date:Fellowship Rare Disease USA Advances in Migraine ManagementRelease Date:Education Internal Medicine USA Exploring the Use of Artificial Intelligence (AI) Applications in ALK+ NSCLCRelease Date:Quality Improvement, Research Oncology Italy Sickle Cell Disease (SCD) FellowshipRelease Date:Fellowship Rare Disease USA Global Call for Collaborators – Pfizer RSV OA ResearchRelease Date:Research Vaccines All 2025 Headache Medicine Fellowship - USRelease Date:Fellowship Internal Medicine USA Sickle Cell Disease Visiting Professorship ProgramRelease Date:Education Rare Disease USA Addressing Barriers to Cancer Care for AIAN and NHPI IndividualsQuality Improvement Oncology USA